Copyright © 2024 Patentskart. All rights reserved
Unleash the Power of Drug Patent Intelligence
Unleash the Power of Drug Patent Intelligence
Empowering smarter decisions in the pharmaceutical landscape.
This refers to a database listing FDA-approved biological drugs (complex medications derived from living organisms). PatentsKart’s Purple Book data provides the first-ever public access to patent details for these drugs, offering valuable insights into intellectual property landscapes.
The Orange Book is the official database maintained by the US Food and Drug Administration (FDA). It lists information on FDA-approved chemical drugs and their generic equivalents. PatentsKart’s Orange Book data offers a user-friendly and accurate way to search for patent information on these drugs.
This section delves into the world of Japanese pharmaceutical patents. PatentsKart provides a comprehensive dataset encompassing all Japanese pharmaceutical patents along with their expiration dates. This information is crucial for understanding market exclusivity and potential competition in the Japanese market.
First-Ever Transparency: Gain comprehensive insights into patents associated with FDA-approved biological drugs. This groundbreaking resource provides a level of transparency never seen before in this field.
Effortless Navigation: Our user-friendly interface streamlines your search process, allowing you to quickly locate the exact patent information you need.
Accurate and Up-to-date: Rest assured you’re working with the latest, most reliable patent data, ensuring informed decision-making.
Seamless Search: PatentsKart’s Orange Book database offers a robust platform to explore patents for FDA-approved chemical drugs.
Enhanced Efficiency: Effortlessly navigate drug-patent connections, saving you valuable time and resources.
Combined Power (Optional): For a truly comprehensive solution, consider our combo package that integrates both Purple and Orange Book patent data, facilitating searches across both categories.
Unmatched Depth: Delve into the extensive world of Japanese pharmaceutical patents with our all-encompassing database.
Expiration Tracking: Strategically plan for the future with our built-in patent expiration date functionality.
A drug patent linkage database connects approved pharmaceutical drugs with their associated patents, helping companies, researchers, and regulators identify patent-protected drugs and plan generic launches accordingly.
It helps assess potential patent barriers, avoid infringement risks, plan generic drug development, and streamline regulatory approvals by linking patents to FDA-approved drugs efficiently.
The database typically includes active patents, patent expiration dates, Orange Book references, patent holders, FDA-approved drug information, and other key regulatory details relevant for IP and drug commercialization decisions.
Most drug patent linkage databases are updated in real-time or periodically to reflect new FDA approvals, patent expirations, litigation outcomes, and changes in regulatory filings, ensuring accurate and actionable data.
Yes. It provides critical insights for patent infringement analysis, freedom-to-operate searches, patent invalidation strategies, and licensing opportunities, making it a valuable tool for pharma IP teams and legal professionals.
United States-13521, 58th St. SE Snohomish, WA – 98290, USA
INDIA - PatentsKart B1, Netsmartz House, IT Park, Chandigarh - 160101
Copyright © 2024 Patentskart. All rights reserved